期刊文献+

凝溶胶蛋白在胃癌组织中的表达及临床意义 被引量:3

Clinical Significance and Expression of GSN in Gastric Cancer Tissue
暂未订购
导出
摘要 目的探讨凝溶胶蛋白(gelsolin,GSN)在胃癌和癌旁组织中的表达及与其临床病理特征的关系。方法采用免疫组化法,检测28例胃癌组织中GSN表达情况。采用蛋白印迹法,检测12例胃癌组织及其对应癌旁组织中GSN表达情况。结果 GSN表达与胃癌肿瘤分化程度、TNM分期、浸润程度、淋巴结有无转移密切相关(P<0.05)。中低分化肿瘤GSN表达水平明显低于高分化肿瘤,晚期胃癌(Ⅲ+Ⅳ)中GSN表达水平明显低于早期胃癌(Ⅰ+Ⅱ),淋巴结转移患者GSN表达水平明显低于无淋巴结转移患者。结论胃癌组织中GSN表达水平明显下降,并随肿瘤进展及分化程度降低而下降,GSN在胃癌发生发展中可能起抑制作用。 Objective To investigate the expression of GSN in gastric carcinoma and para-cancerous tissues and its clinical significance.Methods The expression of GSN was detected by immunohistochemistry in 28 cases of gastric carcinoma patients.Western blot was used to detect the expression of GSN protein in 12 cases of gastric carcinoma and para-cancerous tissues.Results The expression of GSN was significantly correlated with differential degree,TMN staging,serosal infiltration and lymph nodes metastasis of gastric carcinoma tissues(P0.05).The expression of GSN in poorly and moderately differentiated carcinoma was significantly lower than that in well-differentiated carcinoma;the expression of GSN in early gastric cancer was significantly higher than that in advanced gastric cancer,and the expression of GSN in patients with lymph nodes Metastasis was significantly lower than patients without lymph nodes metastasis.Conclusion There is a low expression of GSN in gastric carcinoma tissues,and the degree of the expression of GSN was closely associated with differential degree,TMN staging,serosal infiltration and lymph nodes metastasis of gastric carcinoma tissues,which indicated that GSN might play an inhibitory role in the progress of gastric carcinoma.
出处 《实用癌症杂志》 2012年第6期551-554,558,共5页 The Practical Journal of Cancer
基金 国家自然科学基金项目(81072009 81202009) 上海市自然科学基金(102R1420000)
关键词 胃癌 凝溶胶蛋白 抑癌基因 Gastric carcinoma GSN Tumor suppressor gene
  • 相关文献

参考文献14

  • 1Lueck A, Brown D, Kwiatkowski DJ. The actin-binding pro- teins adseverin and GSN are both highly expressed but dif- ferentially localized in kidney and intestine[J]. J Cell Sci, 1998,18 ( 111 ) :3633.
  • 2Shieh DB, Chen IW, Wei TY, et al. Tissue expression of GSN in oral carcinogenesis progression and its clinicopath- ological implications [J]Oral Oncol,2006,42 (6) :599.
  • 3Sakai N, ohtsu M, Fujita H, et al. Enhancement of G2 checkpoint function by GSN transfection in human cancer cells[J]. Exp Cell Res, 1999,251 ( 1 ) :224.
  • 4Tanaka M, Miillauer L, Ogiso Y, et al. GSN : a candidate for suppressor of human bladder cancer[J] Cancer Res, 1995, 55(15) :3228.
  • 5Aseh HL, Head K, Dong Y, et al. Widespread loss of GSN in breast cancers of humans, mice, and rats [ J ]. Cancer Res, 1996,56(21 ) :4841.
  • 6Dosaka-Akita H, Hommum F, Fujita H, et al. Frequent loss of GSN expression in non-small cell lung cancers of heavy smokers [ J]. Cancer Res, 1998,58 ( 2 ) : 322.
  • 7Kim JH, Choi YK, Kwon H J, et al. Downregulation of GSN and retinoic acid receptor beta expression in gastric cancer tissues through histone deacetylase [ J ].J Gastroenterol Hepatol,2004,19 (2) :218.
  • 8Shieh DB, Chen IW, Wei TY, et al. Tissue expression of GSN in oral carcinogenesis progression and its clinicopath- ologieal implications [ J 3. Oral Oncol, 2006,42 ( 6 ) : 599.
  • 9Ni XG, Zhou L, Wang GQ, et al. The ubiquitin-proteasome pathway mediates gelsolin protein downregulation in pancre- atic cancer[J]. Mol Med,2008,14(9-10) :582.
  • 10Sazawa A,Watanabe T,Tanaka M, et al. Adenovirus media- ted GSN gene therapy for orthotopic human bladder cancer in nude mice[J]. J Urol,2002,168(3):1182.

二级参考文献20

  • 1倪晓光,赵平.泛素-蛋白酶体途径的组成和功能[J].生理科学进展,2006,37(3):255-258. 被引量:43
  • 2Sun HQ,Yamamoto M,Mejillano M,et al.Gelsolin,a multifunctional actin regulatory protein[J].J Biol Chem,1999,274(47):33179.
  • 3Mounzer KC,Moncure M,Smith YR,et al.Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma[J].Am J Respir Crit Care Med,1999,160(5 Pt 1):1673.
  • 4DiNubile MJ,Stossel TP,Ljunghusen OC,et al.Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation[J].Blood,2002,100(13):4367.
  • 5Tanaka M,Mullauer L,Ogiso Y,et al.Gelsolin:a candidate for suppressor of human bladder cancer[J].Cancer Res,1995,55(15):3228.
  • 6Asch HL,Head K,Dong Y,et al.Widespread loss of gelsolin in breast cancers of humans,mice,and rats[J].Cancer Res,1996,56(21):4841.
  • 7Dosaka-Akita H,Hommura F,Fujita H,et al.Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers[J].Cancer Res,1998,58(2):322.
  • 8Kim JH,Choi YK,Kwon HJ,et al.Downregulation of gelsolin and retinoic acid receptor beta expression in gastric cancer tissues through histone deacetylase 1[J].J Gastroenterol Hepatol,2004,19(2):218.
  • 9Shieh DB,Chen IW,Wei TY,et al.Tissue expression of gelsolin in oral carcinogenesis progression and its clinicopathological implications[J].Oral Oncol,2006,42(6):599.
  • 10Noske A,Denkert C,Schober H,et al.Loss of Gelsolin expression in human ovarian carcinomas[J].Eur J Cancer,2005,41(3):461.

共引文献4

同被引文献35

  • 1杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1831
  • 2韩晓曦,王继红,李庆伟.凝溶胶蛋白的结构与功能[J].中国生物化学与分子生物学报,2007,23(5):331-337. 被引量:8
  • 3Lips EH, Mulder L,de Ronde J J, et al. Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristes [J]. Breast Cancer Res Treat, 2012,131 ( 3 ) = 827-836.
  • 4Baig RM, Mahjabeen I, Sabir M, et al. Mutational spectrum of Gelsolin and its down regulation is associated with breast cancer [J]. Dis Markers,2013,34(2) :71-80.
  • 5Megger DA, Bracht T, Kohl M, et al. Proteomic differences be- tween hepatocellular carcinoma and non-tumorous liver tissue in vestigated by a combined 21DIGE and label-free quantitative proteomics study[J]. Mol Cell Proteomics, 2013,12 ( 7 ) : 2006 2020.
  • 6Shirkoohi R, Fujita H, Darmanin S, et al. C-elsolin induces promono cytic leukemia differentiation accompanied by upregulation of p21CIPI[J]. Asian Pac J Cancer Prev,2012,13(9) :4827-4834.
  • 7Jiang X,Zhu S, Panetti TS, et al. Formation of tissue factor fac tor VIIa factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells [J]. Thromb Haemost, 2008,100(1) : 127-133.
  • 8Noske A, Denkert C, Schober H, et al. Loss of Gelsolin expres- sion in human ovarian carcinomas[J]. Eur J Cancer, 2005,41 (3) : 461 469.
  • 9Cunningham (2C, Stossel TP, Kwiatkowski DJ. Enhanced motility in NIH 3T3 Fibroblasts that over express gelsolin[J]. Science, 1991,251(4998) .. 1233-1236.
  • 10Kang X,Sun l.,Guo K,et al. Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-I.C MS/MS[J]. J Cancer Res Clin Oncol,2010,136(8):1151 -1159.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部